Arterial Thrombosis - Pipeline Review, H2 2016

Publisher Name :
Date: 14-Sep-2016
No. of pages: 61
Inquire Before Buying

Global Markets Direct's, ‘Arterial Thrombosis - Pipeline Review, H2 2016', provides an overview of the Arterial Thrombosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Arterial Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Arterial Thrombosis

  • The report reviews pipeline therapeutics for Arterial Thrombosis by companies and universities/research institutes based on information derived from company and industry-specific sources

  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved Arterial Thrombosis therapeutics and enlists all their major and minor projects

  • The report assesses Arterial Thrombosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

  • The report summarizes all the dormant and discontinued pipeline projects

  • The report reviews latest news related to pipeline therapeutics for Arterial Thrombosis

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of therapeutics under development for Arterial Thrombosis

  • Identify potential new clients or partners in the target demographic

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

  • Devise corrective measures for pipeline projects by understanding Arterial Thrombosis pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Arterial Thrombosis - Pipeline Review, H2 2016

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Arterial Thrombosis Overview 7
Therapeutics Development 8
Pipeline Products for Arterial Thrombosis - Overview 8
Pipeline Products for Arterial Thrombosis - Comparative Analysis 9
Arterial Thrombosis - Therapeutics under Development by Companies 10
Arterial Thrombosis - Therapeutics under Investigation by Universities/Institutes 11
Arterial Thrombosis - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Arterial Thrombosis - Products under Development by Companies 15
Arterial Thrombosis - Products under Investigation by Universities/Institutes 16
Arterial Thrombosis - Companies Involved in Therapeutics Development 17
Astellas Pharma Inc. 17
AstraZeneca Plc 18
Bayer AG 19
Bristol-Myers Squibb Company 20
Eisai Co., Ltd. 21
Johnson & Johnson 22
Sanofi 23
Thromboserin Ltd 24
TSRL, Inc. 25
Arterial Thrombosis - Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Target 27
Assessment by Mechanism of Action 29
Assessment by Route of Administration 31
Assessment by Molecule Type 33
Drug Profiles 35
AS-1468240 - Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
ASP-6537 - Drug Profile 36
Product Description 36
Mechanism Of Action 36
R&D Progress 36
BAY-1213790 - Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
BMS-593214 - Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
BMS-654457 - Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
C-3 - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
E-5539 - Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
ER-410660 - Drug Profile 42
Product Description 42
Mechanism Of Action 42
R&D Progress 42
FM-19 - Drug Profile 43
Product Description 43
Mechanism Of Action 43
R&D Progress 43
JNJ-375 - Drug Profile 44
Product Description 44
Mechanism Of Action 44
R&D Progress 44
Peptide to Inhibit PAI-1 for Arterial Thrombosis and Pulmonary Thromboembolism - Drug Profile 45
Product Description 45
Mechanism Of Action 45
R&D Progress 45
PZ-128 - Drug Profile 46
Product Description 46
Mechanism Of Action 46
R&D Progress 46
SAR-216471 - Drug Profile 47
Product Description 47
Mechanism Of Action 47
R&D Progress 47
THL-001 - Drug Profile 48
Product Description 48
Mechanism Of Action 48
R&D Progress 48
ticagrelor - Drug Profile 49
Product Description 49
Mechanism Of Action 49
R&D Progress 49
Arterial Thrombosis - Dormant Projects 57
Arterial Thrombosis - Product Development Milestones 58
Featured News & Press Releases 58
Nov 13, 2014: AstraZeneca announces initiation of development programme for BRILINTA reversal agent 58
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 60
Disclaimer 61

List of Tables

Number of Products under Development for Arterial Thrombosis, H2 2016 8
Number of Products under Development for Arterial Thrombosis - Comparative Analysis, H2 2016 9
Number of Products under Development by Companies, H2 2016 10
Number of Products under Investigation by Universities/Institutes, H2 2016 11
Comparative Analysis by Late Stage Development, H2 2016 12
Comparative Analysis by Clinical Stage Development, H2 2016 13
Comparative Analysis by Early Stage Development, H2 2016 14
Products under Development by Companies, H2 2016 15
Products under Investigation by Universities/Institutes, H2 2016 16
Arterial Thrombosis - Pipeline by Astellas Pharma Inc., H2 2016 17
Arterial Thrombosis - Pipeline by AstraZeneca Plc, H2 2016 18
Arterial Thrombosis - Pipeline by Bayer AG, H2 2016 19
Arterial Thrombosis - Pipeline by Bristol-Myers Squibb Company, H2 2016 20
Arterial Thrombosis - Pipeline by Eisai Co., Ltd., H2 2016 21
Arterial Thrombosis - Pipeline by Johnson & Johnson, H2 2016 22
Arterial Thrombosis - Pipeline by Sanofi, H2 2016 23
Arterial Thrombosis - Pipeline by Thromboserin Ltd, H2 2016 24
Arterial Thrombosis - Pipeline by TSRL, Inc., H2 2016 25
Assessment by Monotherapy Products, H2 2016 26
Number of Products by Stage and Target, H2 2016 28
Number of Products by Stage and Mechanism of Action, H2 2016 30
Number of Products by Stage and Route of Administration, H2 2016 32
Number of Products by Stage and Molecule Type, H2 2016 34
Arterial Thrombosis - Dormant Projects, H2 2016 57

List of Figures

Number of Products under Development for Arterial Thrombosis, H2 2016 8
Number of Products under Development for Arterial Thrombosis - Comparative Analysis, H2 2016 9
Number of Products under Development by Companies, H2 2016 10
Number of Products under Investigation by Universities/Institutes, H2 2016 11
Comparative Analysis by Clinical Stage Development, H2 2016 13
Comparative Analysis by Early Stage Products, H2 2016 14
Assessment by Monotherapy Products, H2 2016 26
Number of Products by Top 10 Targets, H2 2016 27
Number of Products by Stage and Top 10 Targets, H2 2016 27
Number of Products by Top 10 Mechanism of Actions, H2 2016 29
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 29
Number of Products by Routes of Administration, H2 2016 31
Number of Products by Stage and Routes of Administration, H2 2016 31
Number of Products by Molecule Types, H2 2016 33
Number of Products by Stage and Molecule Types, H2 2016 33
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Intravenous Immunoglobulin (IVIg) Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 13-Apr-2017        Price: US 3480 Onwards        Pages: 118
    Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or lot of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Afric......
  • Global Heparin Sodium Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 03-Apr-2017        Price: US 3480 Onwards        Pages: 120
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.Scope of the Report:This report focuses on the Heparin Sodium in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, reg......
  • Hemophilia - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Apr-2017        Price: US 7000 Onwards        Pages: 99
    DelveInsight's "Hemophilia- Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Hemophilia for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Hemophilia from 2013-2023. Hemophilia is the most common inherited bleeding disorder which leads to spontaneous bleeding as the blood does not clot proper......
  • Arterial Thrombosis - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 45
    Arterial Thrombosis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H1 2017, provides an overview of the Arterial Thrombosis (Cardiovascular) pipeline landscape. Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin and coldness. Depending on where the clot forms,......
  • Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 33
    Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2017, provides an overview of the Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline landscape. Deep venous thrombosis is a blood clot that forms in a vein deep inside a part of the body. It mainly affects the large veins in the lower leg and thigh. Symptoms i......
  • Thalassemia - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 140
    Thalassemia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include fussiness, paleness, frequent infections, failure to th......
  • Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 97
    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura - Pipeline Review, H1 2017, provides an overview of the Idiopathic Thrombocytopenic Purpura (Hematological Disorders) pipeline landscape. Idiopathic thrombocytopenic purpura is a bleeding disorder in which the immune system destro......
  • Global Injectable Anticoagulants Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 21-Mar-2017        Price: US 3480 Onwards        Pages: 122
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.Scope of the Report:This report focuses on the Injectable Anticoagulants in Global market, especially in North America, Europe and Asia-Pacific, S......
  • Global Anticoagulants Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 20-Mar-2017        Price: US 3480 Onwards        Pages: 115
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs